Drug Interactions Database

1418 interactions from BNF 85 - Check your medicines

Source: BNF 85
eliglustat edoxaban

increases exposure

Moderate Study
eliglustat everolimus

increases exposure

Moderate Study
eliglustat fexofenadine

increases exposure

Moderate Study
eliglustat loperamide

increases exposure

Moderate Study
eliglustat metoprolol

increases exposure

Moderate Study
eliglustat nortriptyline

increases exposure

Moderate Theoretical
eliglustat paclitaxel

increases exposure

Moderate Study
eliglustat propranolol

increases exposure

Moderate Study
eliglustat sirolimus

increases exposure

Moderate Study
eliglustat taxanes

increases exposure

Moderate Study
eliglustat thrombininhibitors

increases exposure

Moderate Study
eliglustat tolterodine

increases exposure

Moderate Theoretical
eliglustat topotecan

increases exposure

Moderate Study
eliglustat tricyclicantidepressants

increases exposure

Moderate Theoretical
eltrombopag cladribine

increases exposure

Moderate Theoretical
eltrombopag statins

increases exposure

Moderate Study
entacapone levodopa

increases exposure

Moderate Study
enzalutamide amlodipine

decreases exposure

Moderate Study
enzalutamide calciumchannelblockers

decreases exposure

Moderate Study
enzalutamide coumarins

decreases exposure

Moderate Study
enzalutamide felodipine

decreases exposure

Moderate Study
enzalutamide lacidipine

decreases exposure

Moderate Study
enzalutamide lercanidipine

decreases exposure

Moderate Study
enzalutamide nicardipine

decreases exposure

Moderate Study
enzalutamide nifedipine

decreases exposure

Moderate Study
enzalutamide nimodipine

decreases exposure

Moderate Study
erythromycin alfentanil

increases exposure

Moderate Study
erythromycin amlodipine

increases exposure

Moderate Study
erythromycin antiarrhythmics

increases exposure

Moderate Study
erythromycin antiepileptics

increases concentration

Moderate Study
erythromycin atorvastatin

increases exposure

Moderate Study
erythromycin buprenorphine

increases exposure

Moderate Study
erythromycin buspirone

increases exposure

Moderate Study
erythromycin calciumchannelblockers

increases exposure

Moderate Study
erythromycin carbamazepine

increases concentration

Moderate Study
erythromycin corticosteroids

increases exposure

Moderate Study
erythromycin everolimus

increases concentration

Moderate Study
erythromycin fedratinib

increases exposure

Moderate Study
erythromycin felodipine

increases exposure

Moderate Study
erythromycin fentanyl

increases exposure

Moderate Study
erythromycin ivacaftor

increases exposure

Moderate Study
erythromycin lacidipine

increases exposure

Moderate Study
erythromycin lercanidipine

increases exposure

Moderate Study
erythromycin methylprednisolone

increases exposure

Moderate Study
erythromycin midazolam

increases exposure

Moderate Study
erythromycin nicardipine

increases exposure

Moderate Study
erythromycin nifedipine

increases exposure

Moderate Study
erythromycin nimodipine

increases exposure

Moderate Study
erythromycin opioids

increases exposure

Moderate Study
erythromycin oxycodone

increases exposure

Moderate Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.